Neuren Pharmaceuticals
NEU.AX
#5458
Rank
NZ$1.79 B
Marketcap
$13.80
Share price
-9.20%
Change (1 day)
-13.29%
Change (1 year)

Market capitalization of Neuren Pharmaceuticals (NEU.AX)

Market cap: NZ$1.79 Billion

As of November 2024 Neuren Pharmaceuticals has a market cap of NZ$1.79 Billion. This makes Neuren Pharmaceuticals the world's 5458th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neuren Pharmaceuticals from 2005 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$1.79 B-48.28%
2023NZ$3.46 B215.7%
2022NZ$1.09 B112.95%
2021NZ$0.51 B220.43%
2020NZ$0.16 B-39.16%
2019NZ$0.26 B75.35%
2018NZ$0.15 B-53.4%
2017NZ$0.32 B191.41%
2016NZ$0.11 B-48.6%
2015NZ$0.21 B6.18%
2014NZ$0.20 B7.9%
2013NZ$0.18 B261.03%
2012NZ$52.29 M27.55%
2011NZ$41 M358.2%
2010NZ$8.94 M-44.49%
2009NZ$16.11 M414.98%
2008NZ$3.13 M-89.47%
2007NZ$29.73 M-40.68%
2006NZ$50.12 M-9.93%
2005NZ$55.65 M